Apolipoprotein genetic variation in the assessment of atherosclerosis susceptibility
The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Abstract
Apolipoproteins are the protein constituents of lipoproteins, the particles that transport cholesterol and triglycerides in the plasma. Numerous epidemiologic studies have associated variations in plasma levels of lipoproteins and apolipoproteins with the development of atherosclerosis. Furthermore, genetic variations in lipoproteins and apolipoproteins have been associated with disorders of lipid metabolism. Recent advances in biochemical and molecular genetic methods have resulted in an increased understanding of interindividual variations in lipoprotein metabolism and of their relationship to atherosclerosis and the dyslipoproteinemias. In particular, certain DNA restriction fragment length polymorphisms of the apolipoprotein genes have, in the last few years, been associated with atherosclerotic diseases and dyslipoproteinemias. We believe that genetic markers, when used in conjunction with traditional clinical and biochemical determinations, may one day be useful in predicting atherosclerosis susceptibility in the general population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and is a genetically validated target to reduce ASCVD risk.8–10,64–66”
From Clinical review on triglycerides (2020) · cites this paper as [65]
Citations
Cites
The Pathogenesis of Atherosclerosis — An Update
Ross, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140806 · Cited by 4,877
The Metabolic Basis of Inherited Disease.
(1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-3-425_3 · Cited by 2,687
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
Miller, G. J., & Miller, N. E. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92376-4 · Cited by 2,621
A protein cofactor of lecithin:Cholesterol acyltransferase
Fielding, C. J., Shore, V. G., & Fielding, P. E. (1972) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(72)90776-0 · Cited by 724
Weisgraber, K. H., Innerarity, T. L., & Mahley, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34954-8 · Cited by 673
A specific apoprotein activator for lipoprotein lipase
LaRosa, J. C., Levy, R. I., Herbert, P., Lux, S. E., & Fredrickson, D. S. (1970) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(70)90468-7 · Cited by 668
Sniderman, A., Shapiro, S., Marpole, D., Skinner, B., Teng, B., & Kwiterovich, P. O. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.1.604 · Cited by 633
Complete protein sequence and identification of structural domains of human apolipoprotein B
Knott, T. J., Pease, R. J., Powell, L. M., Wallis, S. C., Rall, S. C., Innerarity, T. L., Blackhart, B., Taylor, W. H., Marcel, Y., Milne, R., et al. (1986) · Nature · doi:10.1038/323734a0 · Cited by 620
Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons.
Kane, J. P., Hardman, D. A., & Paulus, H. E. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.5.2465 · Cited by 584
Zannis, V. I., & Breslow, J. L. (1981) · Biochemistry · doi:10.1021/bi00507a059 · Cited by 563
Self-citation
Research works printed but not linked: 21
- Anderson RA, 1986, Apolipoprotein A‐I gene locus haplotypes and HDL‐cholesterol levels, Clin Res, 34, 889A
- Anderson RA, 1985, Apoprotein A‐I linked genetic polymorphisms associated with high density lipoprotein levels, Clin Res, 33, 15
- Antonarakis SE, 1986, DNA polymorphism of the human apolipoprotein AI‐CIII‐AIV gene cluster, Am J Hum Genet (Suppl)., 39, 549
- Assmann G, 1986, Lack of association between RFLPs of the human apolipoprotein CII gene locus and clinical manifestations of atherosclerosis, Am J Hum Genet (Suppl)., 39, 260
- Avogaro P, 1978, Plasma levels of apolipoprotein AI and apoprotein B in human atherosclerosis, Artery., 4, 385
- Chen CH, 1983, Enhancement of Apolipoprotein Ai‐Activated Human Plasma Lecithin: Cholesterol Acyl Transferase Activity by Apoprotein Aii, Arteriosclerosis., 3, 489a
- Cole SA, 1986, A population genetics study of apolipoprotein AI gene polymorphism, Am J Hum Genet (Suppl)., 39, 691
- DHHS, 1980, Lipid Research Clinics Population Studies Data Book. The Prevalence Study, 28
- Fojo SS, 1986, Analysis of apo C‐II patients with apo C‐II deficiency, Circulation, 74, 284
- FrossardP ColemanR FunkeH AssmannG(1985):Molecular genetics of the human apolipoprotein AI‐CIII gene complex: Application to detection of susceptibility to atherosclerosis. In “Proceedings of the 4th International Atherosclerosis Symposium.” Munster GDR.
- Frossard PM, 1986, Genetic markers for coronary atherosclerosis in the human apolipoprotein AI‐CIII‐AIV gene complex, Am J Hum Genet (Suppl)., 39, 589
- Havekes L, 1986, The apolipoprotein E polymorphism at the DNA level, Circulation, 74, 322
- Karathanasis SK, 1986, DNA inversion inactivates both the apo AI and apo CIII genes in patients with combined apo AI‐apo CIII deficiency and premature coronary artery disease, Circulation, 74, 157
- Karathanasis SK, 1984, Apo CIII gene defect in patients with combined apo A‐I‐CIII deficiency and premature atherosclerosis, Arteriosclerosis, 4, 562a
- Kostner GM, 1986, The interactional of lipoproteina with glycosaminoglycans: Possible mechanism for its atherogenicity, Circulation, 74, 25
- Lim D, 1986, Deletion of an Alu sequence in the 5′ of the apolipoprotein AI gene associated with decreased serum HDL‐cholesterol levels, Am J Hum Genet (Suppl)., 39, 621
- Menzel HJ, 1984, Human apolipoprotein A‐I gene polymorphism, J Biol Chem, 259, 3070
- Schaefer EJ, 1986, Apolipoprotein E isoforms in the Framingham Offspring Study: Significance of variant alleles, Circulation, 74, 202
- Schulte H, 1986, The MspI RFLP 3′ to the human apolipoprotein AII gene is neutral with respect to atherosclerosis in Germans, Am J Hum Genet (Suppl)., 39, 293
- Scott J, 1985, High density lipoprotein composition is altered by a common DNA polymorphism adjacent to apolipoprotein A‐II gene in man, Lancet, 1, 770
- Weisgraber KH, 1986, Apolipoprotein B heparin binding sites: Insights into the receptor binding domain, Circulation, 74, 106
Cited by
Clinical review on triglycerides
Laufs, U., Parhofer, K. G., Ginsberg, H. N., & Hegele, R. A. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz785 · Cited by 544
Self-citationBoerwinkle, E., Xiong, W. J., Fourest, E., & Chan, L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.1.212 · Cited by 467
Genetics of hypertriglyceridemia
Dron, J. S., & Hegele, R. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00455 · Cited by 244
Self-citationGenetic factors affecting blood lipoproteins: the candidate gene approach.
Lusis, A. J. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38516-3 · Cited by 221
Leung, S. Y., Ng, T. H., Yuen, S. T., Lauder, I. J., & Ho, F. C. (1993) · Stroke · doi:10.1161/01.str.24.6.779 · Cited by 205
Lipid-Lowering Agents: Targets Beyond PCSK9
Hegele, R. A., & Tsimikas, S. (2019) · Circulation Research · doi:10.1161/circresaha.118.313171 · Cited by 171
“Common genetic variation in the APOC3 gene was recognized as a determinant of plasma TG and HDL-C levels >30 years ago.(111,112) Rare gain-of-function variants in APOC3 are associated with increased VLDL secretion, with increased fasting and postprandial plasma TG levels.”
BackgroundSelf-citationApolipoprotein E and B polymorphisms - longevity factors assessed in nonagenarians
Kervinen, K., Savolainen, M. J., Salokannel, J., Hynninen, A., Heikkinen, J., Ehnholm, C., Koistinen, M. J., & Kesäniemi, Y. A. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90011-6 · Cited by 149
Kaprio, J., Ferrell, R. E., Kottke, B. A., Kamboh, M. I., & Sing, C. F. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.5.1330 · Cited by 119
“-(12) Recent reviews of the structure and function of individual apolipoproteins document their specific roles as ligands, cofactors, and structural components of lipoprotein particles.(13)"(18) As is the case for lipid levels, both genetic and environmental factors are involved in the determination of interindividual…”
BackgroundKamboh, M. I., Ferrell, R. E., & Kottke, B. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38431-5 · Cited by 103
Genetic basis of lipoprotein disorders.
Breslow, J. L. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114176 · Cited by 105
Self-citationGenetic determination of plasma apolipoprotein AI in a population-based sample.
Moll, P. P., Michels, V. V., Weidman, W. H., & Kottke, B. A. (1989) · PubMed · Cited by 90
Plasma levels of apolipoprotein E and genetic markers in elderly patients with Alzheimer's disease
Scacchi, R., Gambina, G., Ruggeri, M., Martini, M. C., Ferrari, G., Silvestri, M., Schiavon, R., & Corbo, R. M. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00889-1 · Cited by 83
Kamboh, M. I., Aston, C. E., Ferrell, R. E., & Hamman, R. F. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90129-i · Cited by 82
Familial hypercholesterolemia and apolipoprotein E4
Eto, M., Watanabe, K., Chonan, N., & Ishii, K. K. (1988) · Atherosclerosis · doi:10.1016/0021-9150(88)90072-x · Cited by 78
Apolipoprotein C-III: Going Back to the Future for a Lipid Drug Target
Huff, M. W., & Hegele, R. A. (2013) · Circulation Research · doi:10.1161/circresaha.113.301464 · Cited by 70
Self-citationHuman Genetics And Coronary Heart Disease: A Public Health Perspective
Hopkins, P. N., & Williams, R. R. (1989) · Annual Review of Nutrition · doi:10.1146/annurev.nu.09.070189.001511 · Cited by 65
Hanis, C. L., Hewett-Emmett, D., Douglas, T. C., Bertin, T. K., & Schull, W. J. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.2.362 · Cited by 57
Tissue-specific methylation patterns and expression of the human apolipoprotein AI gene.
Shemer, R., Walsh, A., Eisenberg, S., Breslow, J. L., & Razin, A. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40151-8 · Cited by 60
Self-citationBoomsma, D. I., Kempen, H. J. M., Leuven, J. A. G., Havekes, L. M., de Knijff, P., & Frants, R. R. (1996) · Genetic Epidemiology · doi:10.1002/(sici)1098-2272(1996)13:1<49::aid-gepi5>3.0.co;2-1 · Cited by 57
Eichner, J. E., Kuller, L. H., Ferrell, R. E., Kamboh, M. I., & Rao, D. C. (1989) · Genetic Epidemiology · doi:10.1002/gepi.1370060404 · Cited by 55
Sepehrnia, B., Kamboh, M. I., Adams-Campbell, L. L., Nwankwo, M. U., & Ferrell, R. E. (1988) · PubMed · Cited by 54
Corbo, R. M., Vilardo, T., Ruggeri, M., Gemma, A. T., & Scacchi, R. (1999) · Clinical Biochemistry · doi:10.1016/s0009-9120(99)00011-9 · Cited by 50
Impact of genetic variation on metabolic response of bone to diet
Cusack, S., & Cashman, K. D. (2003) · Proceedings of The Nutrition Society · doi:10.1079/pns2003308 · Cited by 39
“%) and the ∈ 3 allele is more prevalent in the Japanese (85 v. 75 %; Hegle & Breslow, 1987).”
BackgroundInherited Disorders of Lipid Transport
Schonfeld, G. (1990) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30323-2 · Cited by 33
Corbo, R. M., Vilardo, T., Mantuano, E., Ruggeri, M., Gemma, A. T., & Scacchi, R. (1997) · Clinical Genetics · doi:10.1111/j.1399-0004.1997.tb02522.x · Cited by 32
GENETIC MONITORING AND SCREENING IN THE WORKPLACE
United States. Congress. Office of Technology Assessment. (1990) · University of North Texas Digital Library (University of North Texas) · Cited by 32
Gene-environment interactions in atherosclerosis
Hegele, R. A. (1992) · Molecular and Cellular Biochemistry · doi:10.1007/bf00231537 · Cited by 29
“The genes for most protein products involved in lipoprotein metabolism have been cloned and genetic variants have been identified [8-12].”
BackgroundInfluentialSelf-citationUkkola, O. H., Savolainen, M. J., Salmela, P. I., von Dickhoff, K., & Kesäniemi, Y. A. (1994) · Clinical Genetics · doi:10.1111/j.1399-0004.1994.tb04230.x · Cited by 24
Crews, D. E., Kamboh, M. I., Bindon, J. R., & Ferrell, R. E. (1991) · American Journal of Physical Anthropology · doi:10.1002/ajpa.1330840206 · Cited by 24
Association of an Apolipoprotein B Gene Marker With Essential Hypertension
Frossard, P. M., Obineche, E. N., & Lestringant, G. G. (1999) · Hypertension · doi:10.1161/01.hyp.33.4.1052 · Cited by 23
Deeb, S. S., Failor, R. A., Brown, B. G., Brunzell, J. D., Albers, J. J., Motulsky, A. G., & Wijsman, E. M. (1992) · Human Genetics · doi:10.1007/bf00215683 · Cited by 23
Patsch, W., Patsch, J. R., & Gotto, A. M. (1989) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30643-5 · Cited by 23
Apolipoprotein E alleles and hyperlipoproteinemia in Japan
Eto, M., Watanabe, K., & Ishii, K. K. (1988) · Clinical Genetics · doi:10.1111/j.1399-0004.1988.tb02871.x · Cited by 23
Hegele, R. A., & Dron, J. S. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.313065 · Cited by 22
Self-citationMedical testing and health insurance.
Paton, C. R. (1989) · BMJ · doi:10.1136/bmj.298.6667.134 · Cited by 21
Eichner, J. E., Kuller, L. H., Kamboh, M. I., Ferrell, R. E., Vogler, G. P., & Rao, D. C. (1989) · Genetic Epidemiology · doi:10.1002/gepi.1370060202 · Cited by 19
Genetics and Behavioral Medicine: Risk Factors for Cardiovascular Disease
Vogler, G. P., McClearn, G. E., Snieder, H., Boomsma, D. I., Palmer, R., de Knijff, P., & Slagboom, P. E. (1997) · Behavioral Medicine · doi:10.1080/08964289.1997.10543546 · Cited by 17
Corbo, R. M., Scacchi, R., Rickards, O., Martínez‐Labarga, C., & Stefano, G. F. D. (1999) · American Journal of Human Biology · doi:10.1002/(sici)1520-6300(1999)11:3<297::aid-ajhb2>3.0.co;2-b · Cited by 16
Houlden, H., Crook, R., Duff, K., Hutton, M., Collinge, J., Roques, P. K., Rossor, M. N., & Hardy, J. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11422-s · Cited by 15
Cole, S. A., Szathmáry, E. J. E., & Ferrell, R. E. (1989) · PubMed · Cited by 13
Lipoprotein and Lipid Metabolism
Hegele, R. A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00100-2 · Cited by 12
Self-citationGenetic susceptibility to atherosclerosis.
Breslow, J. L., Deeb, S. A., Lalouel, J.-M., Boeuf, R. L., Schaefer, E. J., Tyroler, H. A., Wilson, P., & Young, S. G. (1989) · Circulation · doi:10.1161/01.cir.80.3.724 · Cited by 12
Self-citationScreening, Diagnosis, and Management of Dyslipoproteinemia on Children
Franklin, F. A., Brown, R. F., & Franklin, C. C. (1990) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30332-3 · Cited by 11
Renard, É., Dupuy, A., Monnier, L., & de Paulet, A. C. (1991) · Diabetic Medicine · doi:10.1111/j.1464-5491.1991.tb01609.x · Cited by 10
Lipoprotein and Lipid Metabolism
Hegele, R. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-812535-9.00007-8 · Cited by 8
Self-citationGenetic Polymorphisms of Apolipoproteins A-IV, E and H in Koreans
Kim, H. S., & Kamboh, M. I. (1998) · Human Heredity · doi:10.1159/000022822 · Cited by 8
Hegele, R. A., Hennekens, C. H., & Breslow, J. L. (1989) · Human Heredity · doi:10.1159/000153855 · Cited by 8
Self-citationApolipoprotein polymorphisms and phenotypic variability in American Samoans: Preliminary data
Crews, D. E., Bindon, J. R., & Kamboh, M. I. (1993) · American Journal of Human Biology · doi:10.1002/ajhb.1310050108 · Cited by 8
Enterocyte Lipid Absorption and Secretion
Davidson, N. O., Magun, A. M., & Glickman, R. M. (1991) · Wiley eBooks · doi:10.1002/cphy.cp060423 · Cited by 7
Clinical Aspects of Gout and Associated Disease States
Newcombe, D. S. (2012) · Springer eBooks · doi:10.1007/978-1-4471-4264-5_5 · Cited by 5
Enterocyte Lipid Absorption and Secretion
Davidson, N. O., Magun, A. M., & Glickman, R. M. (1991) · Comprehensive physiology · doi:10.1002/j.2040-4603.1991.tb01421.x · Cited by 4
Apolipoprotein B gene polymorphisms in patients from Serbia with ischemic cerebrovascular disease
Stanković, A., Stankovic, S., Jovanovic-Markovic, Z., Živković, M., Djurić, T., Glisic-Milosavljevic, S., & Alavantić, D. (2007) · Archives of Biological Sciences · doi:10.2298/abs0704303s · Cited by 4
Epidemiology of Cerebrovascular Disease Among Chinese Canadian Adults With Type 2 Diabetes
Lam, S., & Chu, J. Y. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.02.001 · Cited by 3
“In large-scale studies in Great Britain and Germany, numerous single nuclear polymorphisms that were associated with ischemic stroke and myocardial infarction in white populations were discovered, although it is not clear whether these polymorphisms are specifically associated with large artery atherosclerosis (24).”
BackgroundApplication of molecular techniques to the study of human physiological variation
Ferrell, R. E. (1989) · American Journal of Human Biology · doi:10.1002/ajhb.1310010505 · Cited by 3
Chen, H., Date, C., Nakayama, T., Yoshiike, N., Yamaguchi, M., & Tanaka, H. (1995) · Journal of Epidemiology · doi:10.2188/jea.5.187 · Cited by 2
Chen, H., Date, C., Ikemoto, S., Nakayama, T., Yoshiike, N., Yokoyama, A., Seino, F., Zaman, M. M., Iwaoka, H., Matsumura, Y., et al. (1995) · Journal of Epidemiology · doi:10.2188/jea.5.141 · Cited by 2
Genetic Variation in the Apolipoproteins C-II and C-III
Ferrell, R. E., Kamboh, M. I., Sepehrnia, B., Adams-Campbell, L. L., & Weiss, K. M. (1988) · Advances in experimental medicine and biology · doi:10.1007/978-1-4613-0733-4_11 · Cited by 2
Chu, J. Y., Chu, J. K., & Chung, A. G. (2006) · Cited by 1
Formal Genetics of Humans: Multifactorial Inheritance and Common Diseases
Vogel, F., & Motulsky, A. G. (1997) · Springer eBooks · doi:10.1007/978-3-662-03356-2_7 · Cited by 1
Gene-environment interactions and atherosclerosis.
Hegele, R. A. (1990) · Europe PMC (PubMed Central)
Self-citationUtermann, G. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-24575-6_1
Perimän ja ympäristön vuorovaikutuksen selvittäminen geneettisessä epidemiologiassa
Kaprio, J. A. (1991) · Sosiaalilääketieteellinen Aikakauslehti · doi:10.23990/sa.156265
Metadata
- Authors
- Hegele, R. A., Breslow, J. L., & Cloninger, C. R.
- Affiliations
- Rockefeller University (US)
- Corresponding author
- Breslow, Jan L.
- Venue
- Genetic Epidemiology
- Publisher
- Wiley
- Published
- 1987-01
- Volume
- 4
- Issue
- 3
- Pages
- 163-184
- ISSN
- 0741-0395 (ISSN-L)
- 1098-2272
- OpenAlex
- W1729623267
- Cited by
- 60
- References
- 79
- Citations by year
- 2023: 1 · 2021: 1 · 2020: 2 · 2019: 2 · 2017: 1 · 2013: 2 · 2012: 1
- FWCI
- 12.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Genetic Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- apolipoproteins, atherosclerosis susceptibility, genetic variation, restriction fragment length polymorphism, apolipoprotein genes, dyslipoproteinemia, lipid metabolism disorders, genetic markers, lipoprotein metabolism, cardiovascular risk prediction
- MeSH terms
- Apolipoproteins, Arteriosclerosis, Chromosome Mapping, Disease Susceptibility, Genes, Humans, Polymorphism, Restriction Fragment Length, Genetic Variation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.